Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
01 4Xofigo
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 173
2014 Revenue in Millions : 283
Growth (%) : 64%
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 506
2016 Revenue in Millions : 410
Growth (%) : 23
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 397
2017 Revenue in Millions : 461
Growth (%) : -14%
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 351
2015 Revenue in Millions : 272
Growth (%) : 29
